Turnstone's therapeutic platform is a first - in - class, tumor - targeted oncolytic vaccine that combines potent tumor - killing effects of oncolytic viruses with the benefits of a cancer vaccine that harnesses the patient's own immune system to fight
disease in a sustainable manner.